Emotional processing in the treatment of psychosomatic disorders

Journal of Clinical Psychology
Patricia Coughlin Della Selva

Abstract

Research has supported a hypothesis that was clinically suggested decades ago: that those who have functional disorders exhibit significant deficits in emotional processing. Studies have systematically documented that patients who habitually repress their emotions simultaneously suppress their immune response, rendering them vulnerable to physical illness and early death. Conversely, those who are encouraged to experience and express their feelings demonstrate improvement in immune function, physical condition, and psychological well-being. This article describes a psychotherapy designed to interrupt defensive processes and facilitate the direct experience of previously disavowed feelings in the treatment of patients who have physical ailments. Verbatim transcripts from the treatment of a woman who had a life-threatening illness illustrate the therapeutic techniques designed to facilitate emotional processing and restore health. Data from 14 years of follow-up interviews reveal a sustained remission in her disease.

References

Jan 1, 1989·Diabetic Medicine : a Journal of the British Diabetic Association·H A NeilJ I Mann
Nov 14, 1997·Tropical Medicine & International Health : TM & IH·A Mills
Jul 11, 2006·Journal of Tropical Pediatrics·R C PattinsonR Prinsloo

❮ Previous
Next ❯

Citations

May 22, 2008·Archives of Women's Mental Health·Ephrat Huss, Julie Cwikel
Sep 6, 2008·Cephalalgia : an International Journal of Headache·A AbbassA Purdy
Feb 3, 2007·Journal of Psychosomatic Research·Roger BakerMatthew Owens
Aug 4, 2011·The British Journal of Clinical Psychology·David HambrookTrudie Chalder
Jun 17, 2015·Seizure : the Journal of the British Epilepsy Association·Barbora NovakovaMarkus Reuber
Jul 19, 2018·Qualitative Health Research·Ruth GrahamStephanie Hutton

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.